|
|
|
Volumn 58, Issue 8, 2000, Pages 1747-1762
|
|
Recent studies on anti-angiogenesis in cancer therapy
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 (5 (4 CHLOROPHENYL) 3 (TRIFLUOROMETHYL) 1H PYRAZOL 1 YL)BENZENESULFONAMIDE;
4-(5-(4-CHLOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL)BENZENESULFONAMIDE;
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
ENDOTHELIAL CELL GROWTH FACTOR;
LYMPHOKINE;
MATRIX METALLOPROTEINASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PYRAZOLE DERIVATIVE;
SULFONAMIDE;
VASCULOTROPIN;
VASCULOTROPIN A;
ANIMAL;
DRUG ANTAGONISM;
HUMAN;
MULTIMODALITY CANCER THERAPY;
NEOPLASM;
NEOVASCULARIZATION (PATHOLOGY);
PHYSIOLOGY;
RADIOTHERAPY;
REVIEW;
VASCULARIZATION;
ANGIOGENESIS INHIBITORS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
COMBINED MODALITY THERAPY;
CYCLOOXYGENASE INHIBITORS;
ENDOTHELIAL GROWTH FACTORS;
HUMANS;
LYMPHOKINES;
MATRIX METALLOPROTEINASES;
NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
PYRAZOLES;
RADIOTHERAPY;
SULFONAMIDES;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
|
EID: 0034244294
PISSN: 00471852
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (98)
|
